To start your customized experience click the start button

Customize ?

Start

Cancer Types

Quick Links

CURE Connections^®

Advocacy & Research

Magazines

Magazine Subscription

Award Programs

Ovarian Cancer Heroes

Bone Health Champions

Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Skin Cancer

New Research Aim to 'Get Ahead' of Melanoma by Tracking Its Genetic Evolution

Jessica Skarzynski

Understanding how melanoma spreads can lead to better outcomes. That's what researchers at UCSF aimed to do.

Be Sun Smart During UV Safety Awareness Month

Brielle Urciuoli

July is UV Safety Awareness Month. See three tips on how to protect yourself from harmful UV rays, which are the leading cause of skin cancer.

Cancer Rates 'Soar' in Flight Crew Compared with General Population

Brielle Urciuoli

While having a career as a flight attendant allows individuals to travel the globe, exposure to carcinogens and frequent disruptions in circadian rhythms may increase cancer prevalence in these individuals, according to recent research published in the journal Environmental Health.

FDA Approves Drug Duo for BRAF-Positive Melanoma

Jason M. Broderick

The FDA has approved the combination of the BRAF inhibitor Braftovi (encorafenib) and the MEK inhibitor Mektovi (binimetinib) for the treatment of patients with BRAF-mutant unresectable or metastatic melanoma, as detected by an FDA-approved test.

Keytruda Granted sBLA for Melanoma Treatment

Jason M. Broderick

The FDA has accepted a supplemental biologics license application (sBLA) for the use of Keytruda (pembrolizumab) as an adjuvant treatment for patients with resected, high-risk stage 3 melanoma, according to Merck (MSD), the manufacturer of the PD-1 inhibitor.

It Takes Two

Beth Fand Incollingo

In melanoma, combining two immunotherapies may lower costs and improve quality of life.

New Therapies Are Gathering Speed

WAYNE KUZNAR

Novel immunotherapies either release the immune system’s parking brake or hit its gas pedal.

Contagious Enthusiasm

GINA BATTAGLIA, PH.D.

Oncolytic, or engineered, viruses that infect and kill cancer cells are showing promise.

The Jury Is Out

MEERI KIM, PH.D.

Checkpoint inhibitors can be extremely effective for the right patients, but identifying who will benefit remains an imprecise science.

Under New Management

Andrew Smith

A new expert guideline for managing immunotherapy’s side effects has been released.

Skin Cancer

Sign In

Sign Up